tirzepatide.vs semaglutide Tirzepatide caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Semaglutide vs Tirzepatide for Weight

In research-material sourcing, it is commonly grouped near tissue-support, barrier-function, structural-integrity, and repair-category research models

You can also read more about the Wegovy injection on our dedicated page

Yes, gastrointestinal side effects such as nausea, vomiting, diarrhea, and decreased appetite may recur even if you previously tolerated tirzepatide well, as your system readjusts to the medication

[PubMed: 5050425] 62

The appetite decrease is of course part of the intended mechanism, but it can become excessive during aggressive titration, leading to inadequate caloric and protein intake

Once in the blood capillaries, DPP-4 quickly degrades the molecule, and the drug is excreted by the kidneys